| RS2057448454 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2057454001 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2057483219 |
KAT8
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Li-Ghorbani-Weisz-Hubshman syndrome |
| RS2057490468 |
FBXO7
|
Health Risk |
Pathogenic/Likely pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2057499255 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2057499617 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS2057501802 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2057531939 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2057538050 |
KAT8
|
Health Risk |
Pathogenic |
Li-Ghorbani-Weisz-Hubshman syndrome, Li-Ghorbani-Weisz-Hubshman syndrome |
| RS2057538160 |
KAT8
|
Health Risk |
Pathogenic |
Li-Ghorbani-Weisz-Hubshman syndrome, Li-Ghorbani-Weisz-Hubshman syndrome |
| RS2057541040 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2057541271 |
RUNX1
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2057541324 |
RUNX1
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Abnormal bleeding |
| RS2057544094 |
LAMA1
|
Health Risk |
Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2057587604 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2057587984 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2057593272 |
PGAP3
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS2057610007 |
LAMA1
|
Health Risk |
Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2057643696 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2057660103 |
LAMA1
|
Health Risk |
Pathogenic |
— |
| RS2057661952 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS2057666079 |
PMS1
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS2057699910 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2057717676 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2057721188 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2057722066 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2057730983 |
LAMA1
|
Health Risk |
Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2057734561 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2057736834 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS2057739636 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2057740525 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2057753419 |
STAG2
|
Health Risk |
Pathogenic |
Holoprosencephaly 13, X-linked |
| RS2057764630 |
SYN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, X-linked 1 |
| RS2057771219 |
SYN1
|
Health Risk |
Pathogenic |
Seizure, Epilepsy |
| RS2057777177 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2057777813 |
SYN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, X-linked 1 |
| RS2057789980 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2057840623 |
STAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mullegama-Klein-Martinez syndrome, Mullegama-Klein-Martinez syndrome |
| RS2057842904 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2057848462 |
LAMA1
|
Health Risk |
Pathogenic |
— |
| RS2057883934 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS2057891984 |
SYN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 50 |
| RS2057892179 |
SYN1
|
Health Risk |
Pathogenic |
— |
| RS2057900552 |
SYN1
|
Health Risk |
Likely pathogenic |
Epilepsy, X-linked 1 |
| RS2057914149 |
DNAAF4
|
Health Risk |
Likely pathogenic |
— |
| RS2057934167 |
WDR4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2057941229 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2057941303 |
SYN1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 50 |
| RS2057942403 |
SYN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, X-linked 1 |
| RS2057947681 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS2057948232 |
CACNA1A
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 6, Spinocerebellar ataxia type 6 |
| RS2057948502 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2057953268 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2057955936 |
RFXAP
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2057986431 |
IL10RA;LOC130006833
|
Health Risk |
Pathogenic |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS2057989087 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2057997150 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2057997486 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2057998063 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2057998110 |
RUNX1
|
Health Risk |
Pathogenic |
Abnormal bleeding, Thrombocytopenia |
| RS2057999400 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2058001839 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2058002908 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Acute myeloid leukemia |
| RS2058004321 |
RUNX1
|
Health Risk |
Pathogenic |
Thrombocytopenia, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2058028450 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
TTN-related disorder, Cardiomyopathy |
| RS2058028669 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2058029089 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2058033367 |
STAG2
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS2058035458 |
LAMA1
|
Health Risk |
Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2058036751 |
IL10RA
|
Health Risk |
Pathogenic |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS2058057299 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2058068934 |
RBL2
|
Health Risk |
Pathogenic |
Brunet-Wagner neurodevelopmental syndrome, Brunet-Wagner neurodevelopmental syndrome |
| RS2058143736 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2058146182 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2058161147 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2058179740 |
DNAAF4
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 25, Primary ciliary dyskinesia 25 |
| RS2058187525 |
XPNPEP3
|
Health Risk |
Pathogenic |
Nephronophthisis-like nephropathy 1, Nephronophthisis-like nephropathy 1 |
| RS2058205143 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2058229729 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2058237051 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2058265845 |
PSMB10
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 5, Proteasome-associated autoinflammatory syndrome 5 |
| RS2058265858 |
PSMB10
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 5, Proteasome-associated autoinflammatory syndrome 5 |
| RS2058270689 |
RBP4
|
Health Risk |
Likely pathogenic |
Microphthalmia, isolated |
| RS2058283703 |
RBP4
|
Health Risk |
Pathogenic |
Progressive retinal dystrophy due to retinol transport defect, Retinal dystrophy |
| RS2058288753 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2058298885 |
LCAT
|
Health Risk |
Conflicting classifications of pathogenicity |
LCAT deficiency, Cardiovascular phenotype |
| RS2058305359 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS2058311848 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2058315149 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2058320138 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2058321851 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2058330715 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2058347214 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2058350211 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2058354383 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2058357329 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2058357396 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS2058357964 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2058358025 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2058358241 |
SPG7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |